194 related articles for article (PubMed ID: 23712384)
1. FTIR spectroscopy of biofluids revisited: an automated approach to spectral biomarker identification.
Ollesch J; Drees SL; Heise HM; Behrens T; Brüning T; Gerwert K
Analyst; 2013 Jul; 138(14):4092-102. PubMed ID: 23712384
[TBL] [Abstract][Full Text] [Related]
2. It's in your blood: spectral biomarker candidates for urinary bladder cancer from automated FTIR spectroscopy.
Ollesch J; Heinze M; Heise HM; Behrens T; Brüning T; Gerwert K
J Biophotonics; 2014 Apr; 7(3-4):210-21. PubMed ID: 24395618
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
4. Low- and high-grade bladder cancer determination via human serum-based metabolomics approach.
Bansal N; Gupta A; Mitash N; Shakya PS; Mandhani A; Mahdi AA; Sankhwar SN; Mandal SK
J Proteome Res; 2013 Dec; 12(12):5839-50. PubMed ID: 24219689
[TBL] [Abstract][Full Text] [Related]
5. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
6. Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder.
Chen G; Wang B; Li H; Ma X; Shi T; Zhang X
Urol Oncol; 2013 May; 31(4):475-9. PubMed ID: 22079940
[TBL] [Abstract][Full Text] [Related]
7. Detection of cancer using advanced computerized analysis of infrared spectra of peripheral blood.
Ostrovsky E; Zelig U; Gusakova I; Ariad S; Mordechai S; Nisky I; Kapilushnik J
IEEE Trans Biomed Eng; 2013 Feb; 60(2):343-53. PubMed ID: 23193226
[TBL] [Abstract][Full Text] [Related]
8. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
9. Vibrational biospectroscopy coupled with multivariate analysis extracts potentially diagnostic features in blood plasma/serum of ovarian cancer patients.
Owens GL; Gajjar K; Trevisan J; Fogarty SW; Taylor SE; Da Gama-Rose B; Martin-Hirsch PL; Martin FL
J Biophotonics; 2014 Apr; 7(3-4):200-9. PubMed ID: 24259229
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
[TBL] [Abstract][Full Text] [Related]
11. Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma.
Babjuk M; Soukup V; Pesl M; Kostírová M; Drncová E; Smolová H; Szakacsová M; Getzenberg R; Pavlík I; Dvorácek J
Urology; 2008 Apr; 71(4):718-22. PubMed ID: 18387400
[TBL] [Abstract][Full Text] [Related]
12. Fourier-transform infrared spectroscopy coupled with a classification machine for the analysis of blood plasma or serum: a novel diagnostic approach for ovarian cancer.
Gajjar K; Trevisan J; Owens G; Keating PJ; Wood NJ; Stringfellow HF; Martin-Hirsch PL; Martin FL
Analyst; 2013 Jul; 138(14):3917-26. PubMed ID: 23325355
[TBL] [Abstract][Full Text] [Related]
13. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.
Kibar Y; Goktas S; Kilic S; Yaman H; Onguru O; Peker AF
Ann Clin Lab Sci; 2006; 36(1):31-8. PubMed ID: 16501234
[TBL] [Abstract][Full Text] [Related]
15. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
17. Segregation of ovarian cancer stage exploiting spectral biomarkers derived from blood plasma or serum analysis: ATR-FTIR spectroscopy coupled with variable selection methods.
Lima KM; Gajjar KB; Martin-Hirsch PL; Martin FL
Biotechnol Prog; 2015; 31(3):832-9. PubMed ID: 25832726
[TBL] [Abstract][Full Text] [Related]
18. Biospectroscopy insights into the multi-stage process of cervical cancer development: probing for spectral biomarkers in cytology to distinguish grades.
Purandare NC; Patel II; Trevisan J; Bolger N; Kelehan R; von Bünau G; Martin-Hirsch PL; Prendiville WJ; Martin FL
Analyst; 2013 Jul; 138(14):3909-16. PubMed ID: 23338619
[TBL] [Abstract][Full Text] [Related]
19. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
20. Bladder cancer diagnosis from bladder wash by Fourier transform infrared spectroscopy as a novel test for tumor recurrence.
Gok S; Aydin OZ; Sural YS; Zorlu F; Bayol U; Severcan F
J Biophotonics; 2016 Sep; 9(9):967-75. PubMed ID: 27041149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
